KK
Kanchan Kumari Soni
About Kanchan Kumari Soni
Data last updated:
Kanchan Kumari Soni is a Director at Narvs Pharma Private Limited (since 2022) and Director at Nskin Pharma Private Limited (since 2022). The companies operate in Chemicals. The largest current company by reported revenue is Narvs Pharma Private Limited at ₹94.2 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Narvs Pharma Private Limited U74900DL2015PTC277334 | Director | 25 Mar 2022 | 2015 | ₹94.2 Lakh (FY 2024) | Active |
 Nskin Pharma Private Limited U24230DL2022PTC404648 | Director | 15 Sep 2022 | 2022 | Active |
Board colleagues of Kanchan Kumari Soni
| Name | DIN | Company | Designation |
|---|---|---|---|
| Babli Kumari | 09550488 | Narvs Pharma Private Limited | Director |
| Navneet Kumar | 06952022 | Narvs Pharma Private Limited , Nskin Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kanchan Kumari Soni
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kanchan Kumari Soni
Kanchan Kumari Soni currently holds 2 directorships: Narvs Pharma Private Limited (Director, since 25 Mar 2022, revenue ₹94.2 Lakh (FY 2024)); Nskin Pharma Private Limited (Director, since 15 Sep 2022).
Kanchan Kumari Soni was first appointed on 25 Mar 2022 as Director at Narvs Pharma Private Limited.
The current boards of Kanchan Kumari Soni's companies include Babli Kumari (Narvs Pharma Private Limited), Navneet Kumar (Narvs Pharma Private Limited).